Navigation Links
International Isotopes Inc. Announces Successful International Standards Certification for Manufacture of Its Nuclear Medicine Products and Devices
Date:8/1/2011

IDAHO FALLS, Idaho, Aug. 1, 2011 /PRNewswire/ -- International Isotopes Inc. (OTC Bulletin Board: INIS) announces it has received certification under both ISO-9001 and ISO-13485 standards for the manufacture and design of many of its nuclear medicine and cobalt-60 products.

"ISO" is the International Organization for Standardization, a powerful international standards setting body that promulgates worldwide commercial quality standards for manufacture of a wide range of products and processes.  ISO certification requires rigorous inspection and validation by a certifying body to ensure that the company has an extensive Quality Assurance Program meeting all of the ISO elements and a demonstrated commitment for continuous improvement.    

Steve T. Laflin, INIS President and CEO stated, "The ISO certifications are important to the Company's plans for continued expansion of sales of several products into international markets.  The ISO certification also improves our capabilities and value as a contract manufacturer of nuclear medicine products for RadQual LLC.  While the certification itself is certainly an important milestone for the Company it is really the beginning of what must be an ongoing process to continually improve.  In addition to permitting expansion of the Company's international sales, the ISO processes will also directly benefit our customers in terms of the quality of the products we produce and the service we provide."

About International Isotopes Inc.

International Isotopes Inc. manufactures a full range of nuclear medicine calibration and reference standards, high purity fluoride gases, and a variety of cobalt-60 products such as teletherapy sources.  The Company also provides a wide selection of radioisotopes and radiochemicals for medical devices, calibration, clinical research, life sciences, and industrial applications and provides a host of analytical, measurement, recycling, and processing services on a contract basis to clients.

International Isotopes Inc. Safe Harbor Statement

Certain statements in this press release are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements with respect to the importance of the ISO certifications to the Company's ability to expand sales or any direct benefit to our customers or shareholders.  Information contained in such forward-looking statements is based on current expectations and is subject to change.  These statements involve a number of risks, uncertainties and other factors that could cause actual results, performance or achievements of International Isotopes, Inc. to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Other factors, which could materially affect such forward-looking statements, can be found in International Isotopes, Inc.'s filings with the Securities and Exchange Commission at www.sec.gov, including our annual report on Form 10-K for the year ending December 31, 2010.  Investors, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements.  The forward-looking statements made herein are only made as of the date of this press release and International Isotopes, Inc. undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

FOR MORE INFORMATION CONTACT:
Jim Drewitz
Creative Options Communications
Investor and Public Relations
jim@jdcreativeoptions.com
Phone:  830-669-2466

For more information, please visit the Company web site:  www.internationalisotopes.com


'/>"/>
SOURCE International Isotopes Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Dyadic International Announces Date of Second Quarter 2011 Financial Results Release and Conference Call
2. Roka Bioscience Participates in the International Association for Food Protection Conference
3. Daval International Announces Completion of Phase II Trial for the Treatment of Bladder Dysfunction With AIMSPRO® in Secondary Progressive Multiple Sclerosis
4. NAFG Announces Expanded International Surrogacy and Egg Donation Program
5. New Thriller Exposes International Bioterrorism Plot that Leaves the Human Race on the Brink of Certain Disaster
6. Cord Blood America CEO Matthew Schissler Interviewed on International Successes
7. International Isotopes Inc. Announces the Selection of Parsons as the Lead Design-Build Contractor for the Proposed Depleted Uranium De-Conversion Facility
8. Fiberstar Posts Strong Second Quarter Operating Results on Continued Rising International Demand
9. OXIS International Names Healthcare Industry Entrepreneur David Saloff to Board of Directors
10. New Zealand Brings Its Global "Game Plan" to the 2011 BIO International Convention
11. Dyadic International Enters Into Research and License Agreement With Major Player in the Animal Feed Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2017)... ... 2017 , ... The first human cell line HeLa, established in 1951, has ... cross-contamination of human cell lines with HeLa cells were published. Until recently, cross-contamination and ... and is associated with dramatic consequences for research. , In this educational webinar, ...
(Date:6/22/2017)... MA (PRWEB) , ... June 22, 2017 , ... Charm ... ILVO validation. The AMPH test was determined to be appropriate as a screening test ... visual interpretation, on the Charm EZ system, and the Charm EZ Lite system. These ...
(Date:6/20/2017)... Florida (PRWEB) , ... June 20, 2017 , ... Biologist ... in men. While researching her latest book, Men Chase, Women Choose: The Neuroscience of ... that love has a physiological effect on men. ”The logical next step, in my ...
(Date:6/20/2017)... June 20, 2017  Kibow Biotech Inc., a pioneer ... the issuance of a new patent covering a unique ... the U.S. Patent and Trademark Office on May 23 ... the Buzz of Bio award in 2014 in ... developing non-drug approaches to chronic disease. Renadyl™, the first ...
Breaking Biology Technology:
(Date:4/5/2017)... 5, 2017 Today HYPR Corp. , ... server component of the HYPR platform is officially ... end-to-end security architecture that empowers biometric authentication across Fortune ... already secured over 15 million users across the financial ... connected home product suites and physical access represent a ...
(Date:3/30/2017)... 30, 2017  On April 6-7, 2017, Sequencing.com will ... hackathon at Microsoft,s headquarters in ... focus on developing health and wellness apps that provide ... the Genome is the first hackathon for personal ... largest companies in the genomics, tech and health industries ...
(Date:3/28/2017)... -- The report "Video Surveillance Market by ... Devices), Software (Video Analytics, VMS), and Service (VSaaS, Installation ... 2022", published by MarketsandMarkets, the market was valued at ... reach USD 75.64 Billion by 2022, at a CAGR ... considered for the study is 2016 and the forecast ...
Breaking Biology News(10 mins):